Controversy Over NAS Letter Rages On

Five months after it was delivered, a July letter from the National Academy of Sciences to a foreign associate member suggesting that he resign because of his alleged anti-Semitic activities is still generating controversy. Correspondence expressing support for the move, as well as letters protesting it, continue to arrive at the NAS office; two scientific societies have joined the chorus of supporters. The issue has focused attention on the criteria for membership in the academy, prompting so

Written byBarbara Spector
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

The issue has focused attention on the criteria for membership in the academy, prompting some to question the statement in the NAS bylaws that one's scientific contributions are the only determining factor.

The debate centers on Russian mathematician Igor R. Shafarevich, head of the algebra section of the V.A. Steklov Institute in Moscow, the mathematics institute of the Russian Academy of Sciences (Barbara Spector, The Scientist, Sept. 28, 1992, page 1). In the 1970s, Shafarevich was a critic of the Soviet government, advocating increased human rights in the USSR.

The letter, signed by academy president Frank Press and foreign secretary James Wyngaarden, refers to "your anti-Semitic writings as contained in Russophobia," a text Shafarevich wrote in 1982 that has been circulated increasingly over the past three years. "Moreover," the letter continues, "we are informed that there are few, if any, Jewish members of the Steklov Institute in Moscow."

The letter ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies